Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gillis Otten

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Vaccine|November 5, 2019
A phase 1, randomized, observer blind, antigen and adjuvant dosage finding clinical trial to evaluate the safety and immunogenicity of an adjuvanted, trivalent subunit influenza vaccine in adults ≥ 65 years of ageGillis Otten, Vincent Matassa, Max Ciarlet, et al.
Current Protocols in Immunology|April 25, 2008
Flow cytometry analysis using the Becton Dickinson FACS CaliburKevin L Holmes, Gillis Otten, Wayne M Yokoyama
Human Vaccines & Immunotherapeutics|July 27, 2012
MF59 oil-in-water emulsion in combination with a synthetic TLR4 agonist (E6020) is a potent adjuvant for a combination Meningococcus vaccineManmohan Singh, Jina Kazzaz, Mildred Ugozzoli, et al.
Journal of Pharmaceutical Sciences|February 9, 2018
The Preparation and Physicochemical Characterization of Aluminum Hydroxide/TLR7a, a Novel Vaccine Adjuvant Comprising a Small Molecule Adsorbed to Aluminum HydroxidePadma Malyala, Donatello Laera, Simona Cianetti, et al.
Vaccines|September 8, 2015
Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in SituYen Cu, Kate E Broderick, Kaustuv Banerjee, et al.
Vaccine|June 15, 2004
Enhancement of DNA vaccine potency in rhesus macaques by electroporationGillis Otten, Mary Schaefer, Barbara Doe, et al.
Vaccine|July 6, 2013
Generation of a parvovirus B19 vaccine candidateSumana Chandramouli, Angelica Medina-Selby, Doris Coit, et al.
Journal of Virology|April 30, 2003
Induction of broad and potent anti-human immunodeficiency virus immune responses in rhesus macaques by priming with a DNA vaccine and boosting with protein-adsorbed polylactide coglycolide microparticlesGillis Otten, Mary Schaefer, Catherine Greer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2011
A point mutation in the amino terminus of TLR7 abolishes signaling without affecting ligand bindingCarlo Iavarone, Katrin Ramsauer, Andriy V Kubarenko, et al.
Journal of Virology|October 18, 2005
Evaluation of envelope vaccines derived from the South African subtype C human immunodeficiency virus type 1 TV1 strainYing Lian, Indresh Srivastava, V Rául Gómez-Román, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Vaccine|November 5, 2019
A phase 1, randomized, observer blind, antigen and adjuvant dosage finding clinical trial to evaluate the safety and immunogenicity of an adjuvanted, trivalent subunit influenza vaccine in adults ≥ 65 years of ageGillis Otten, Vincent Matassa, Max Ciarlet, et al.
Current Protocols in Immunology|April 25, 2008
Flow cytometry analysis using the Becton Dickinson FACS CaliburKevin L Holmes, Gillis Otten, Wayne M Yokoyama
Human Vaccines & Immunotherapeutics|July 27, 2012
MF59 oil-in-water emulsion in combination with a synthetic TLR4 agonist (E6020) is a potent adjuvant for a combination Meningococcus vaccineManmohan Singh, Jina Kazzaz, Mildred Ugozzoli, et al.
Journal of Pharmaceutical Sciences|February 9, 2018
The Preparation and Physicochemical Characterization of Aluminum Hydroxide/TLR7a, a Novel Vaccine Adjuvant Comprising a Small Molecule Adsorbed to Aluminum HydroxidePadma Malyala, Donatello Laera, Simona Cianetti, et al.
Vaccines|September 8, 2015
Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in SituYen Cu, Kate E Broderick, Kaustuv Banerjee, et al.
Vaccine|June 15, 2004
Enhancement of DNA vaccine potency in rhesus macaques by electroporationGillis Otten, Mary Schaefer, Barbara Doe, et al.
Vaccine|July 6, 2013
Generation of a parvovirus B19 vaccine candidateSumana Chandramouli, Angelica Medina-Selby, Doris Coit, et al.
Journal of Virology|April 30, 2003
Induction of broad and potent anti-human immunodeficiency virus immune responses in rhesus macaques by priming with a DNA vaccine and boosting with protein-adsorbed polylactide coglycolide microparticlesGillis Otten, Mary Schaefer, Catherine Greer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2011
A point mutation in the amino terminus of TLR7 abolishes signaling without affecting ligand bindingCarlo Iavarone, Katrin Ramsauer, Andriy V Kubarenko, et al.
Journal of Virology|October 18, 2005
Evaluation of envelope vaccines derived from the South African subtype C human immunodeficiency virus type 1 TV1 strainYing Lian, Indresh Srivastava, V Rául Gómez-Román, et al.
Pageof 2